Table 1.
Descriptive Statistics for Self-Reported Erectile Dysfunction and Potential Demographic, Metabolic Risk, and Mental Health Correlates in 18–31 Year-Old Males Reporting Past-Year Sexual Activity, 2013 Growing Up Today Study (n= 2,660)
| M | SD | % | N | |
|---|---|---|---|---|
| Erectile Dysfunction | ||||
| International Index of Erectile Function-5 (IIEF-5) Scores | ||||
| Level of Erectile Dysfunction (Score Range) | ||||
| No Erectile Dysfunction (22–25) | 85.8% | 2,283 | ||
| Mild Erectile Dysfunction (17–21) | 11.3% | 300 | ||
| Mild-Moderate Erectile Dysfunction (12–16) | 2.0% | 52 | ||
| Moderate (8–11) or Severe (5–7) Erectile Dysfunction | 0.9% | 25 | ||
| Overall IIEF-5 Scale Score | 23.47 | 2.54 | ||
| Any Past Year Use of Erectile Dysfunction Prescription Medication or Supplement | 2.0% | 64 | ||
| Source of the medication or supplement | ||||
| Prescribed by a health care provider | 35.9% | 23 | ||
| Prescribed to someone else | 17.2% | 11 | ||
| Purchased abroad or online without proof of prescription | 12.5% | 8 | ||
| Over the counter (no prescription required) | 31.3% | 20 | ||
| Specialty health or natural food store | 21.9% | 14 | ||
| Demographics | ||||
| Age in Years | 25.82 | 3.33 | ||
| Currently Married/Living with a Partner | 39.9% | 1,062 | ||
| Metabolic Syndrome Risk Indicators | ||||
| Overweight or obese weight status | 20.3% | 539 | ||
| Waist circumference >40 inches | 9.4% | 250 | ||
| Diabetes | 1.1% | 28 | ||
| Hypertension | 6.3% | 168 | ||
| Hypercholesterolemia | 7.7% | 205 | ||
| Number of Metabolic Syndrome Risk Indicators | ||||
| ≥1 metabolic syndrome risk indicator | 33.8% | 899 | ||
| ≥2 metabolic syndrome risk indicators | 7.5% | 200 | ||
| ≥3 metabolic syndrome risk indicators | 1.7% | 44 | ||
| Mental Health (History of Clinical Diagnosis) | ||||
| Depression | 11.1% | 296 | ||
| Anxiety | 8.4% | 224 | ||
| Use of Antidepressant Medication (Past Year) | 5.6% | 149 | ||
| Selective serotonin re-uptake inhibitors (SSRIs, e.g., Prozac) | 4.5% | 119 | ||
| Other antidepressants (e.g., Elavil, Tofranil) | 2.0% | 52 | ||
| Use of Tranquilizers (Past Year; e.g., Valium, Xanax) | 2.3% | 62 |
Note: Scores on the IIEF-5 range from 5–25, with lower scores indicating greater degrees of erectile dysfunction. Weight status was based on body mass index calculated from self-reported height and weight. Waist circumference was measured via self-report using a tape measure provided to survey participants. Participants were scored as having diabetes, hypertension, or hypercholesterolemia if they indicated that a health provider diagnosed them with the condition, and/or if they indicated taking medication for the condition. Participants were scored as having depression or anxiety by self-report if a health provider diagnosed them with the condition in the past.